The scientist’s investigation covers issues in Radiation therapy, Prostate cancer, Nuclear medicine, Oncology and Internal medicine. His Radiation therapy study incorporates themes from Prostatectomy, Prostate and Urology. Mack Roach has researched Prostate cancer in several fields, including Clinical trial and Toxicity.
His research in Nuclear medicine intersects with topics in Gold marker, Radiation treatment planning, Rectum, Fiducial marker and Carcinoma. He has included themes like Localized disease, Survival analysis, Chemotherapy and Disease in his Oncology study. His work in the fields of Internal medicine, such as Cancer, intersects with other areas such as Risk assessment.
His scientific interests lie mostly in Prostate cancer, Radiation therapy, Internal medicine, Oncology and Prostate. His biological study spans a wide range of topics, including Radiology and Brachytherapy. His biological study deals with issues like Hormonal therapy, which deal with fields such as Androgen suppression.
His work carried out in the field of Oncology brings together such families of science as Androgen, Survival analysis, Disease and Goserelin. His research integrates issues of Radiation treatment planning, Rectum, Nuclear medicine, Magnetic resonance imaging and Stage in his study of Prostate. His Nuclear medicine research incorporates themes from Dose fractionation and Planning target volume.
His primary scientific interests are in Prostate cancer, Internal medicine, Oncology, Radiation therapy and Radiology. His work deals with themes such as Randomized controlled trial, Prostate and Brachytherapy, which intersect with Prostate cancer. Mack Roach focuses mostly in the field of Prostate, narrowing it down to topics relating to Nuclear medicine and, in certain cases, Genitourinary system and Common Terminology Criteria for Adverse Events.
The various areas that Mack Roach examines in his Oncology study include Toxicity, Phases of clinical research, Meta-analysis, Disease and Hormonal therapy. Radiation therapy is a subfield of Surgery that Mack Roach tackles. His research in Radiology intersects with topics in Systematic review and Contrast.
Mack Roach mainly investigates Prostate cancer, Internal medicine, Radiation therapy, Oncology and Clinical trial. The Prostate cancer study combines topics in areas such as Prostate, Radiology and Brachytherapy. His Prostate research includes elements of Nuclear medicine and Urology.
His Radiation therapy research is within the category of Surgery. His Oncology research integrates issues from Consensus conference, Disease, Evidence-based medicine, Hormone sensitive prostate cancer and Hormonal therapy. His Clinical trial research incorporates elements of Cancer, Cancer registry, Medical physics and Patient participation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
Mack Roach;Gerald Hanks;Howard Thames;Paul Schellhammer.
International Journal of Radiation Oncology Biology Physics (2006)
Prostate cancer. Clinical practice guidelines in oncology.
James Mohler;Robert R. Bahnson;Barry Boston;J. Erik Busby.
Journal of The National Comprehensive Cancer Network (2010)
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
James L. Mohler;Emmanuel S. Antonarakis;Andrew J. Armstrong;Anthony V. D'Amico.
Journal of The National Comprehensive Cancer Network (2019)
Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases.
William F. Harstell;Charles B. Scott;Deborah Watkins Bruner;Charles W. Scarantino.
Journal of the National Cancer Institute (2005)
Short-Term Neoadjuvant Androgen Deprivation Therapy and External-Beam Radiotherapy for Locally Advanced Prostate Cancer: Long-Term Results of RTOG 8610
Mack Roach;Kyounghwa Bae;Joycelyn Speight;Harvey B. Wolkov.
Journal of Clinical Oncology (2008)
Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413.
Mack Roach;M. DeSilvio;C. Lawton;V. Uhl.
Journal of Clinical Oncology (2003)
Prostate Cancer, Version 1.2016
James L. Mohler;Andrew J. Armstrong;Robert R. Bahnson;Anthony Victor D'Amico.
Journal of The National Comprehensive Cancer Network (2016)
An Update of the Phase III Trial Comparing Whole Pelvic to Prostate Only Radiotherapy and Neoadjuvant to Adjuvant Total Androgen Suppression: Updated Analysis of RTOG 94-13, With Emphasis on Unexpected Hormone/Radiation Interactions
Colleen A. Lawton;Michelle DeSilvio;Mack Roach;Valery Uhl.
International Journal of Radiation Oncology Biology Physics (2007)
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group.
Peter Grimm;Ignace Billiet;David Bostwick;Adam P Dicker.
Low-dose megavoltage cone-beam CT for radiation therapy.
Jean Pouliot;Ali Bani-Hashemi;Josephine Chen;Michelle Svatos.
International Journal of Radiation Oncology Biology Physics (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: